Pharmaceutical Executive, Nov 1, 2008 - Pharmaceutical Executive

ADVERTISEMENT
Pharmaceutical Executive, Nov 1, 2008
Features
RxClub Awards 2008: Powerful & Simple
By Brittany Agro
Top Rx Club Award winners exhibit qualities that ironically juxtapose industry's paradigm (pdf)
Gilding Lilly
By Joanna Breitstein
Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?
The Mess in MS
A five-year forecast of the multiple-sclerosis market following the disruptions of Tysabri
Pharm Exec Q&A: Tommy Thompson
By Patrick Clinton
The former health secretary offers a reality check on healthcare reform—and what to expect from the pols in '09
Tech Toys
By George Koroneos, Online Content & News Editor
Here are the hottest gadgets and gizmos to make a dent in drug noncompliance
Columns
Making Sense of Sales
Don't throw out sales force effectiveness with the sales force—some sure-fire strategies
Docs Rock the Vote
By Brittany Agro
Medical journal advertising takes center stage at the sixth-annual Doctor's Choice Awards
All You Need to Know About SEO
When it comes to search engine optimization, here's how to earn Google's respect
Washington Report
Resolving Conflicting Interests
By Jill Wechsler
As Congress moves to curb industry influence, support for med ed is waning
From the Editor
Over There
By Patrick Clinton
Is FDA's MO in foreign inspections too broken to fix?
Back Page
Big Science
HIV infection unzips its genes
Thought Leader
No Ordinary Joe
It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?
Leadership
Size Doesn't Matter
By Sander Flaum, Flaum Partners
Evaluating experience: It's what you know, not how long you know it
Global Report
Cash Flow Woes in EU
By Sarah Houlton
In Europe, it's different strokes for different folks at the top regulatory agencies

ADVERTISEMENT

Click here